ALS2CR8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.423200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.651000E-01
Normal-vs-Stage2
3.331800E-01
Normal-vs-Stage3
1.996780E-01
Normal-vs-Stage4
4.754800E-01
Stage1-vs-Stage2
2.491200E-01
Stage1-vs-Stage3
9.580800E-03
Stage1-vs-Stage4
6.550200E-01
Stage2-vs-Stage3
1.324500E-03
Stage2-vs-Stage4
1.489350E-01
Stage3-vs-Stage4
5.585800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.463400E-01
Normal-vs-AfricanAmerican
3.081000E-01
Normal-vs-Asian
5.609700E-02
Caucasian-vs-AfricanAmerican
6.209600E-01
Caucasian-vs-Asian
5.285600E-01
AfricanAmerican-vs-Asian
9.877400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.236200E-01
Normal-vs-Female
3.670200E-01
Male-vs-Female
2.288200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.897000E-01
Normal-vs-Age(41-60Yrs)
4.086400E-01
Normal-vs-Age(61-80Yrs)
3.203400E-01
Normal-vs-Age(81-100Yrs)
2.734600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.030400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.186800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.737200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.227900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.620200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.575200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.176400E-01
Normal-vs-Daily Drinker
2.924600E-01
Normal-vs-Weekly Drinker
6.113500E-02
Normal-vs-Occasional Drinker
3.854400E-01
Normal-vs-Social Drinker
2.156000E-01
Non Drinker-vs-Daily Drinker
6.059400E-01
Non Drinker-vs-Weekly Drinker
9.770600E-01
Non Drinker-vs-Occasional Drinker
3.486400E-01
Non Drinker-vs-Social Drinker
1.596990E-01
Daily Drinker-vs-Weekly Drinker
6.736200E-01
Daily Drinker-vs-Occasional Drinker
1.719630E-01
Daily Drinker-vs-Social Drinker
1.297390E-01
Weekly Drinker-vs-Occasional Drinker
4.990200E-01
Weekly Drinker-vs-Social Drinker
3.107000E-01
Occasional Drinker-vs-Social Drinker
6.016800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.554300E-02
Normal-vs-Grade 2
1.967710E-02
Normal-vs-Grade 3
2.274400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.514400E-01
Grade 1-vs-Grade 3
7.431400E-01
Grade 1-vs-Grade 4
8.554300E-02
Grade 2-vs-Grade 3
4.406000E-01
Grade 2-vs-Grade 4
1.967710E-02
Grade 3-vs-Grade 4
2.274400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.043600E-01
Normal-vs-NonDiabetic
3.278200E-01
Diabetic-vs-NonDiabetic
4.972000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.182400E-01
Normal-vs-NoPancreatitis
3.283400E-01
Pancreatitis-vs-NoPancreatitis
8.081800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.887800E-02
Normal-vs-N1
3.338000E-01
N0-vs-N1
5.516600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.764600E-01
Normal-vs-TP53-NonMutant
4.704600E-01
TP53-Mutant-vs-TP53-NonMutant
1.108570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
